EA202092190A1 - Композиции и способы для лечения сильного запора - Google Patents
Композиции и способы для лечения сильного запораInfo
- Publication number
- EA202092190A1 EA202092190A1 EA202092190A EA202092190A EA202092190A1 EA 202092190 A1 EA202092190 A1 EA 202092190A1 EA 202092190 A EA202092190 A EA 202092190A EA 202092190 A EA202092190 A EA 202092190A EA 202092190 A1 EA202092190 A1 EA 202092190A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- compositions
- methods
- severe construction
- dgat1
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
В данном изобретении предлагаются способы, относящиеся к лечению или профилактике дисфункции желудочно-кишечного тракта у субъекта, нуждающегося в этом, которые включают использование ингибитора диацилглицерин-O-ацилтрансферазы 1 (DGAT1). В данном изобретении также предлагаются фармацевтические композиции, содержащие ингибитор DGAT1, или его фармацевтически приемлемые соли или сложные эфиры, пригодные для лечения, описанного в данном документе.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862644033P | 2018-03-16 | 2018-03-16 | |
PCT/US2019/022499 WO2019178492A1 (en) | 2018-03-16 | 2019-03-15 | Compositions and methods for treating severe constipation |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202092190A1 true EA202092190A1 (ru) | 2020-11-19 |
Family
ID=67904819
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202092190A EA202092190A1 (ru) | 2018-03-16 | 2019-03-15 | Композиции и способы для лечения сильного запора |
Country Status (16)
Country | Link |
---|---|
US (2) | US11224590B2 (ru) |
EP (1) | EP3765012A4 (ru) |
JP (1) | JP2021518431A (ru) |
KR (1) | KR20200136428A (ru) |
CN (1) | CN111936137B (ru) |
AU (1) | AU2019234956A1 (ru) |
BR (1) | BR112020018790A2 (ru) |
CA (1) | CA3093970A1 (ru) |
EA (1) | EA202092190A1 (ru) |
IL (1) | IL277332A (ru) |
MX (1) | MX2020009604A (ru) |
PE (1) | PE20210158A1 (ru) |
PH (1) | PH12020551468A1 (ru) |
SG (1) | SG11202008971VA (ru) |
TW (1) | TWI704917B (ru) |
WO (1) | WO2019178492A1 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3765012A4 (en) | 2018-03-16 | 2021-12-15 | Anji Pharmaceuticals Inc. | COMPOSITIONS AND METHODS OF TREATMENT OF SERIOUS CONSTIPATION |
KR20220052459A (ko) | 2020-10-21 | 2022-04-28 | 주식회사 엘지에너지솔루션 | 전극 탭 고정부를 포함하는 용접장치 및 이를 이용한 전극 탭 용접 방법 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2008012406A (es) * | 2006-03-31 | 2008-10-07 | Novartis Ag | Compuestos nuevos. |
JO2972B1 (en) * | 2007-06-08 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Piperidine / piperazine derivatives |
WO2009112445A1 (en) * | 2008-03-10 | 2009-09-17 | Novartis Ag | Method of increasing cellular phosphatidyl choline by dgat1 inhibition |
US9061012B2 (en) * | 2010-03-30 | 2015-06-23 | Novartis Ag | Uses of DGAT1 inhibitors |
CA2794849A1 (en) * | 2010-04-08 | 2011-10-13 | Medicinova, Inc. | Methods and compositions for the treatment of irritable bowel syndrome |
AR083417A1 (es) * | 2010-10-14 | 2013-02-21 | Novartis Ag | Composiciones farmaceuticas que contienen un dgat1 inhibidor |
WO2013130370A2 (en) | 2012-03-01 | 2013-09-06 | Merck Sharp & Dohme Corp. | Compounds as dgat-1 inhibitors |
WO2013169648A1 (en) * | 2012-05-07 | 2013-11-14 | Novartis Ag | Pharmaceutical combinations comprising a dgat1 inhibtor and a triglyceride lowering drug |
RU2015111258A (ru) * | 2012-08-29 | 2016-10-20 | Саликс Фармасьютикалз, ИНК. | Слабительные композиции и способы лечения запора и связанных с ним желудочно-кишечных заболеваний и состояний |
SG11201604706TA (en) * | 2014-01-09 | 2016-07-28 | Sanofi Sa | Stabilized pharmaceutical formulations of insulin aspart |
EP3765012A4 (en) | 2018-03-16 | 2021-12-15 | Anji Pharmaceuticals Inc. | COMPOSITIONS AND METHODS OF TREATMENT OF SERIOUS CONSTIPATION |
-
2019
- 2019-03-15 EP EP19767984.8A patent/EP3765012A4/en active Pending
- 2019-03-15 JP JP2020573085A patent/JP2021518431A/ja active Pending
- 2019-03-15 SG SG11202008971VA patent/SG11202008971VA/en unknown
- 2019-03-15 EA EA202092190A patent/EA202092190A1/ru unknown
- 2019-03-15 US US16/355,085 patent/US11224590B2/en active Active
- 2019-03-15 MX MX2020009604A patent/MX2020009604A/es unknown
- 2019-03-15 PE PE2020001407A patent/PE20210158A1/es unknown
- 2019-03-15 AU AU2019234956A patent/AU2019234956A1/en active Pending
- 2019-03-15 BR BR112020018790-9A patent/BR112020018790A2/pt unknown
- 2019-03-15 CN CN201980019537.3A patent/CN111936137B/zh active Active
- 2019-03-15 WO PCT/US2019/022499 patent/WO2019178492A1/en unknown
- 2019-03-15 CA CA3093970A patent/CA3093970A1/en active Pending
- 2019-03-15 KR KR1020207029661A patent/KR20200136428A/ko unknown
- 2019-03-18 TW TW108109164A patent/TWI704917B/zh active
-
2020
- 2020-09-14 PH PH12020551468A patent/PH12020551468A1/en unknown
- 2020-09-14 IL IL277332A patent/IL277332A/en unknown
-
2021
- 2021-12-30 US US17/565,584 patent/US11819495B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
KR20200136428A (ko) | 2020-12-07 |
EP3765012A4 (en) | 2021-12-15 |
IL277332A (en) | 2020-10-29 |
EP3765012A1 (en) | 2021-01-20 |
PH12020551468A1 (en) | 2021-09-01 |
TWI704917B (zh) | 2020-09-21 |
WO2019178492A1 (en) | 2019-09-19 |
SG11202008971VA (en) | 2020-10-29 |
CN111936137B (zh) | 2023-09-08 |
US11819495B2 (en) | 2023-11-21 |
MX2020009604A (es) | 2023-01-25 |
US20190282549A1 (en) | 2019-09-19 |
AU2019234956A1 (en) | 2020-10-01 |
US20220193044A1 (en) | 2022-06-23 |
PE20210158A1 (es) | 2021-01-26 |
CA3093970A1 (en) | 2019-09-19 |
US11224590B2 (en) | 2022-01-18 |
TW201944995A (zh) | 2019-12-01 |
BR112020018790A2 (pt) | 2020-10-13 |
CN111936137A (zh) | 2020-11-13 |
JP2021518431A (ja) | 2021-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA202090676A1 (ru) | Способы введения некоторых vmat2-ингибиторов | |
NZ765590A (en) | Diaryl substituted 5,5-fused ring compounds as c5ar inhibitors | |
JOP20200122B1 (ar) | مركبات مفيدة لتثبيط cdk7 | |
EA202190960A1 (ru) | Конденсированные пирролины, которые действуют как ингибиторы убиквитин-специфической протеазы 30 (usp30) | |
PH12018501956A1 (en) | 3-desoxy derivative and pharmaceutical compositions thereof | |
MX2020006459A (es) | Compuestos de anillos fusionados 6,5 diaril sustituidos como inhibidores de c5ar. | |
EA202090932A1 (ru) | Способы введения некоторых vmat2-ингибиторов | |
EA201691454A1 (ru) | Композиции придопидина модифицированного высвобождения | |
EA200971115A1 (ru) | Новые ингибиторы обратной транскриптазы вич | |
EA201692268A1 (ru) | Ингибиторы фосфатидилинозитол-3-киназы | |
EA202090052A1 (ru) | Содержащие имидазол ингибиторы alk2 киназы | |
EA201992116A1 (ru) | Фармацевтические составы флороглюцинола и триметилфлороглюцинола | |
PH12017500029A1 (en) | 4,5-dihydroisoxazole derivatives as nampt inhibitors | |
EA202191239A1 (ru) | Соединения и их применение для лечения дефицита 1-антитрипсина | |
EA201692470A1 (ru) | Фармацевтические комбинации | |
EA201990765A1 (ru) | Азаиндазольные соединения для применения при повреждениях сухожилий и/или связок | |
EA202092829A1 (ru) | Композиции тофацитиниба с контролируемым высвобождением | |
EA202090424A1 (ru) | Бициклические ингибиторы гистондеацетилазы | |
EA202192322A1 (ru) | Фармацевтические составы | |
EA202192925A1 (ru) | Твердые формы ингибитора glyt1 | |
EA202092190A1 (ru) | Композиции и способы для лечения сильного запора | |
EA201691792A1 (ru) | Фармацевтические составы на основе вилдаглиптина | |
EA202190057A1 (ru) | Солюбилизированные апиразы, способы и применение | |
EA201990766A1 (ru) | Индазольные соединения для применения при повреждениях сухожилий и/или связок | |
EA201892528A1 (ru) | Трехкомпонентная комбинация чистых антагонистов 5-htрецепторов, ингибиторов ацетилхолинэстеразы и антагониста nmda рецептора |